EE177 Economic Impact of Contrast-Induced Nephropathy in Percutaneous Coronary Intervention: A Medicare Payer Perspective

Abstract

Authors

AM McGovern AP Amin R Cavalcante A Bhave L Hargens RI Griffiths

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×